Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms

SARS-CoV-2 infection can associate diverse neurological manifestations. Several studies have provided proof to support the theory of neurotropic involvement of SARS-CoV-2. Alpha-synuclein has been described as a native antiviral factor within neurons, and upregulation of this protein can be seen in...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology 2021-09, Vol.268 (9), p.3116-3124
Hauptverfasser:	Blanco-Palmero, V. A., Azcárate-Díaz, F. J., Ruiz-Ortiz, M., Laespada-García, M. I., Rábano-Suárez, P., Méndez-Guerrero, A., Aramendi-Ramos, M., Eguiburu, J. L., Pérez-Rivilla, A., Marchán-López, A., Rubio-Fernández, M., Carro, E., González de la Aleja, J.
Format:	Artikel
Sprache:	eng
Schlagworte:	alpha-Synuclein Animals Basal ganglia Brain Diseases Central nervous system diseases Cerebrospinal fluid Coronaviruses COVID-19 Encephalopathy Humans Invasiveness Medicine Medicine & Public Health Movement disorders Myoclonus Neurology Neurons Neuroradiology Neurosciences Original Communication SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Synuclein
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!